| # | Drug | Count |
|---|---|---|
| 0 | TREPROSTINIL | 74 |
| 1 | ASPIRIN | 58 |
| 2 | ASPIRIN 325 MG | 57 |
| 3 | ASPIRIN 81 MG | 57 |
| 4 | FUROSEMIDE | 53 |
| 5 | SILDENAFIL CITRATE | 46 |
| 6 | MACITENTAN | 44 |
| 7 | AMBRISENTAN | 38 |
| 8 | CLOPIDOGREL | 36 |
| 9 | TADALAFIL | 35 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ANHYDROUS CITRIC ACID, SODIUM BICARBONATE (HEAT-TREATED) | 1 | 0.0417 |
| 1 | FENOPROFEN CALCIUM | 1 | 0.0204 |
| 2 | MOEXIPRIL HYDROCHLORIDE | 1 | 0.0149 |
| 3 | TOLMETIN SODIUM | 1 | 0.0059 |
| 4 | OLSALAZINE SODIUM | 1 | 0.0051 |
| 5 | ECONAZOLE NITRATE | 2 | 0.0021 |
| 6 | CAMPHOR, CAPSAICIN, MENTHOL | 1 | 0.0019 |
| 7 | MENTHOL, UNSPECIFIED FORM | 1 | 0.0016 |
| 8 | POTASSIUM ACETATE | 2 | 0.0014 |
| 9 | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE | 1 | 0.0013 |
| # | Drug class | Count |
|---|---|---|
| 0 | Prostacycline Vasodilator [EPC] | 84 |
| 1 | Endothelin Receptor Antagonist [EPC] | 82 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 73 |
| 3 | Loop Diuretic [EPC] | 59 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 59 |
| 5 | Phosphodiesterase 5 Inhibitor [EPC] | 54 |
| 6 | Corticosteroid [EPC] | 34 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 33 |
| 8 | Cardiac Glycoside [EPC] | 32 |
| 9 | Osmotic Laxative [EPC] | 31 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Prostacyclin Receptor Agonist [EPC] | 24 | 0.0009 |
| 1 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |
| 2 | Prostacycline Vasodilator [EPC] | 84 | 0.0006 |
| 3 | Provitamin D2 Compound [EPC] | 16 | 0.0005 |
| 4 | Soluble Guanylate Cyclase Stimulator [EPC] | 16 | 0.0005 |
| 5 | alpha-Hydroxy Acid [EPC] | 1 | 0.0005 |
| 6 | Cardiac Glycoside [EPC] | 32 | 0.0004 |
| 7 | Semifluorinated Alkane [EPC] | 1 | 0.0004 |
| 8 | Vitamin D2 Analog [EPC] | 3 | 0.0004 |
| 9 | Nitrogen Binding Agent [EPC] | 1 | 0.0004 |